{"disease":{"id":"covid-19-immunisation","name":"covid 19 immunisation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06646406","title":"Evaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination Rate","phase":"NA","overall_status":"COMPLETED","enrollment_count":114165,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04785144","title":"Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":135,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT04283461","title":"Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06205524","title":"A Study to Evealuate Safety and Immunogenicity of TI-0010 SARS-CoV-2 Vaccine in Healthy Adults","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"National Drug Clinical Trial Institute of the Second Affiliated Hospital of Bengbu Medical College","has_results":false},{"nct_id":"NCT04788459","title":"Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":68,"lead_sponsor_name":"Takis","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}